Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel backs Gilead Sciences' hepatitis C drug
FDA panel backs Gilead Sciences' hepatitis C drug
FDA panel backs Gilead Sciences' hepatitis C drug
Submitted by
admin
on October 26, 2013 - 8:07am
Source:
Yahoo/AP
News Tags:
Gilead
FDA
advisory panels
hepatitis C
sofosbuvir
Headline:
FDA panel backs Gilead Sciences' hepatitis C drug
Do Not Allow Advertisers to Use My Personal information
